Hedge funds tweak short bets on German Evotec and FUCHS stocks

German biotech firm Evotec saw a hedge fund reduce its short position, with AHL Partners lowering its net short exposure from 0.78 % to 0.68 % on 8 June 2026. The firm’s shares were trading around €4.83, down 2 % on the day, while other funds such as ActusRayPartners, Highbridge Capital Management, Mirabella Financial Services and Acadian Asset Management continue to hold modest short positions.

In the chemicals sector, specialist lubricant maker FUCHS faced an increase in short interest as Pertento Partners raised its net short stake from 0.90 % to 1.00 % on 5 June 2026. The stock was priced at €32.50 with a modest daily gain. The rise pushes the short position above the 1 % threshold that often signals heightened investor skepticism.

Both cases reflect ongoing scrutiny by professional investors of German equities, with hedge funds adjusting exposure based on their assessment of company outlooks and market dynamics.